MeiraGTx Holdings plc – Material Contracts Watch

EX-10.3

from 8-K 14 pages Registration Rights Agreement

12/34/56

EX-10.2

from 8-K 33 pages Certain Information Marked as [***] Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential

12/34/56

EX-10.1

from 8-K 115 pages Certain Information Marked as [***] Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential

12/34/56

EX-10.2

from 10-Q 5 pages Amendment No. 5 to Amended and Restated Notes Purchase Agreement ​

12/34/56

EX-10.3

from 8-K 51 pages ​ Certain Information Marked as [***] Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. ​ Collaboration and License Agreement by and Among Hologen Neuro Ai Limited, Hologen Neuro Ai Uk Limited, Hologen Limited, MeiraGTx Holdings plc, Meiragtx Neuro Uk Limited and Meiragtx Neuro I, LLC ​ April 20, 2026 ​

12/34/56

EX-10.2

from 8-K 14 pages Certain Information Marked as [***] Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential

12/34/56

EX-10.1

from 8-K 20 pages Certain Information Marked as [***] Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential

12/34/56

EX-10.2

from 8-K 6 pages Certain Information Marked as [***] Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Second Termination Agreement

12/34/56

EX-10.1

from 8-K 63 pages Certain Information Marked as [***] Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. ​ Asset Purchase Agreement Dated as of April 15, 2026 by and Between Janssen Pharmaceuticals, Inc., Meiragtx Ocular Uk Limited and Solely for Purposes of Section 5.15, MeiraGTx Holdings plc

12/34/56

EX-10.53

from 10-K 6 pages Amendment No. 4 to Amended and Restated Notes Purchase Agreement and Amendment No. 1 to Warrant Certificates

12/34/56

EX-10.52

from 10-K 94 pages Certain Information Marked as [***] Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential. Strategic Collaboration and License Agreement Among, Eli Lilly and Company, MeiraGTx Ocular Uk Limited, MeiraGTx Limited and MeiraGTx Uk II Limited ​

12/34/56

EX-10.1

from 8-K 7 pages Certain Information Marked as [***] Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Share Purchase Agreement

12/34/56

EX-10.1

from 10-Q 63 pages Certain Information Marked as [***] Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Lease Agreement

12/34/56

EX-10.51

from 10-K 68 pages (Continued) ​

12/34/56

EX-10.50

from 10-K 51 pages Certain Information Marked as [***] Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. ​ Form of ​ Collaboration and License Agreement by and Among Hologen Neuro Ai Ltd, Hologen Neuro Ai Uk Limited, Hologen Limited, MeiraGTx Holdings plc, Meiragtx Neuro Uk Limited and Meiragtx Neuro I, LLC ​ , 2025 ​

12/34/56

EX-10.49

from 10-K 59 pages Certain Information Marked as [***] Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Hologen Neuro Ai Limited Framework Agreement Dated as of March 9, 2025

12/34/56

EX-10.24

from 10-K 130 pages Certain Information Marked as [***] Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Customarily and Actually Treats as Private or Confidential. Collaboration, Option and License Agreement by and Between Janssen Pharmaceuticals, Inc., Meiragtx Uk II Limited and MeiraGTx Holdings plc

12/34/56

EX-10.1

from 10-Q 3 pages ​ MeiraGTx Holdings PLC ​ Non-Employee Director Compensation Program

12/34/56

EX-10.48

from 10-K 6 pages Certain Information Marked as [***] Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Termination Agreement

12/34/56

EX-10.47

from 10-K 55 pages Certain Information Marked as [***] Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. ​ ​ ​ ​ ​ Asset Purchase Agreement Dated as of December 20, 2023 by and Among Janssen Pharmaceuticals, Inc., Meiragtx Uk II Limited and MeiraGTx Holdings PLC ​ ​ ​ ​ ​

12/34/56